Michael Rafii, MD
Enriched profileProfessor of Clinical Neurology and Medical Director, Epstein Family Alzheimer's Therapeutic Research Institute (ATRI), Keck School of Medicine of USC · Keck School of Medicine of the University of Southern California (USC)
Michael Rafii is Professor of Clinical Neurology and Medical Director, Epstein Family Alzheimer's Therapeutic Research Institute (ATRI), Keck School of Medicine of USC at Keck School of Medicine of the University of Southern California (USC). OpenAlex indexes 227 publications with 10,320 citations (h-index 47); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Michael Rafii, MD, PHD, is Professor of Clinical Neurology and Medical Director, Epstein Family Alzheimer's Therapeutic Research Institute (ATRI), Keck School of Medicine of USC at Keck School of Medicine of the University of Southern California (USC). The public record shows 227 publications with 10,320 citations (h-index 47), centered on Alzheimer's / Dementia. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 8 companies, 6 NIH-funded awards (2014–2025).
- Most recent indexed publication: 2026 · Alzheimer's & dementia (Amsterdam, Netherlands)
- Top research focus: Alzheimer's / Dementia
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atrinews.usc.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Sponsor: Michael Rafii, MD, PhD
- Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
Sponsor: Alzheimer's Disease and Related Disorders Association, Inc
Industry payments
Updated 27 Aug 2026
8 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20257 payments$34,409openpaymentsdata.cms.gov ↗
- Ionis Pharmaceuticals, Inc.Program year20256 payments$25,920openpaymentsdata.cms.gov ↗
- Otsuka Pharmaceutical Co., Ltd.Program year20259 payments
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Platelet Aggregation Inhibitor100%Aspirin-Dipyridamole Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2014–2025 per NIH RePORTER. The latest:
- Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study
Medical University of South Carolina
FY2026$2,047,117R01AG095004 - Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study
Medical University of South Carolina
FY2025$2,072,617R01AG095004 - Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome
University of Southern California
FY2025$604,405R01AG073979
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 Trial.
Alzheimer's & dementia (Amsterdam, Netherlands)
Article2026 - Exploring automated plasma phospho-tau217 assays for the diagnosis of Down syndrome-related Alzheimer's disease.
Communications medicine
Article2026 - Serum and cerebral folate are normal in Down Syndrome Regression Disorder.
Molecular autism
Article2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/michael-s-rafii-md-phd-5025294
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Michael-Rafii
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/michael-rafii-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/USCATRI/posts/atris-own-gustavo-jimenez-maggiora-and-michael-s-rafii-md-phd-will-be-speaking-a/787879510210921
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
keck.usc.edu/news/watch-usc-atris-michael-rafii-md-phd-talk-with-actc-colleague-jason-karlawish-md-about-his-latest-book
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keck.usc.edu ↗ - Other
theluckyfewpodcast.com/episodes/315-alzheimers-downsyndrome
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theluckyfewpodcast.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Warren Alpert Medical School of Brown University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗ - PhD
Brown University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗ - Board Certified
American Board of Psychiatry & Neurology - Neurology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗
- Member
National Task Group on Intellectual Disabilities and Dementia Practices, American Academy of Developmental Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →today.usc.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗
Secondary affiliations
appointments beyond the home institution- Principal Investigator
NIH-funded Alzheimer's Clinical Trials Consortium - Down Syndrome (ACTC-DS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗ - Director
Medical Safety Unit, Alzheimer's Clinical Trials Consortium (ACTC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗ - Co-Director
Clinical Core, Alzheimer's Disease Neuroimaging Initiative (ADNI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atri.usc.edu ↗
Media & interviews
press, podcasts and appearances- Featured guest
The Alzheimer's Research Podcast (ATRI) - "The Earliest Clues: How Genetic Populations Illuminate the Path to Alzheimer's Prevention"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atrinews.usc.edu ↗ - Featured guest
The Lucky Few podcast, Episode 315: "Brain Health & DS: Alzheimer's Disease Prevalence and Treatment"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theluckyfewpodcast.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →usagainstalzheimers.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.